Dr. Mark Israel, Former Director Of Dartmouth’s Cancer Center, Named National Executive Director Of The Israel Cancer Research Fund

Read more...

Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ...  Scientific Achievement is in our DNA ... Supporting World-Class Cancer Research in Israel ...  Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ... Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ...Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ... Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ... Scientific Achievement is in our DNA ... Supporting World-Class Cancer Research in Israel ...  Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ... Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ... Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ... Scientific Achievement is in our DNA ... Supporting World-Class Cancer Research in Israel ...

ICRF | Connecticut
Location: 
Private Home
Date: 
Monday, August 17, 2015

Monday, August 17th 7:30 pm, Stamford, CT 

Hear Latest Developments in in Ovarian, Breast and Brain Cancers 

Meet ICRF Scientist ROTEM KARNI, Ph.D.  

Assistant Professor and Chair, Program of Biochemistry, Metabolism and Endocrinology 

The Hebrew University-Hadassah Medical School

 

At a private home 

RSVP for location: 203 321-1006

David.Kweskin@ICRFonline.org

Join us for an Evening of Learning. No solicitation of funds. 

 

Some highlights of Dr. Karni's research:

• Discovered the mechanism involved in breast cancer cell growth leading to early detection, treatment.

• Identified a genetic protein likely to be involved in the development and spread of glioblastoma, the most common and aggressive type of brain cancer in adults.

• Found a process in which cancer cells become resistant to certain drugs, leading to reliable prediction of which patients will most be helped by chemotherapy and which will not.            

He leads a team who focus on alternative RNA splicing and how splicing factors contribute to cancer development, tumor progression and the metastatic process.

http://www.icrfonline.org/discoveries-icrf-researchers-point-new-therapy...

Time: 
Monday, August 17, 2015 - 7:30pm